Clinical partners
Collaborate on ethically approved cohorts, clinical annotation, imaging review, pathology context, and longitudinal follow-up.
BRIDGE welcomes clinical, scientific, computational, and translational partners who want to contribute to longitudinal brain metastasis research, data harmonization, atlas development, or controlled-access collaborative studies.
Benefits: BRIDGE membership could provide early access to the BRIDGE Data Resource, consortium updates, collaboration opportunities, and participation in data harmonization, atlas development, working groups, or workshops, subject to relevant policies and approvals.
Collaborate on ethically approved cohorts, clinical annotation, imaging review, pathology context, and longitudinal follow-up.
Develop experimental and translational studies that connect brain metastasis biology with therapeutic resistance and recurrence.
Contribute analysis workflows for single-cell, spatial, genome-architecture, imaging, and integrative multi-omic resources.
For general BRIDGE collaboration, contact either coordination address. For sample and data contribution specifically, use the Contribute Samples / TRACE page so that consent, IRB, and data-governance requirements can be aligned early.